Trial Profile
Clinical Trials Insight: 700032157
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Apr 2008
Price :
$35
*
At a glance
- Drugs GED aPC (Primary)
- Indications Cardiogenic shock; Embolism and thrombosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Correvio Pharma
- 03 Apr 2008 New trial record.